Principal Assistant for Research and Technology

Dr. George V. Ludwig, Principal Assistant for Research and Technology

Dr. George V. Ludwig
Dr. George V. Ludwig,
Principal Assistant for Research
and Technology

George V. Ludwig is the Principal Assistant for Research and Technology with the U.S. Army Medical Research and Materiel Command (USAMRMC), MEDCOM where he is responsible for developing and implementing medical research policy, facilitating strategic partnerships, and coordinating medical research and development intellectual capital and physical infrastructure. Dr. Ludwig plays an integral role in the planning, programming, budgeting, and execution processes for the science and technology components of a $1.5 billion per year medical RDT&E effort. He has led USAMRMC efforts to establish a new overseas laboratory in Tbilisi, Georgia, serving as a strategic facilitator between Georgian government and the US DoD. His recent efforts to codify, organize and manage USAMRMC scientific and technical competencies have helped the Command ensure it has the capabilities required to develop medical products in support of the warfighter.

Previously Dr. Ludwig served as the Civilian Deputy to the Principal Assistant for Research and Technology. Prior to that role he was the Science Director at the United States Army Research Institute of Infectious Diseases where he helped USAMRIID meet the challenges of a changing national and international biodefense landscape. He led a strategic reorganization effort designed to improve laboratory science operations efficiencies and strategic planning. He also served as a leader in developing and enhancing DoD, industry, and academic strategic partnerships. Dr. Ludwig also served as Chief of the Diagnostic Systems Division at USAMRIID where he coordinated a program for development of advanced diagnostics capable of identifying potential biological threats and other high-hazard infectious and non-infectious disease agents. Dr. Ludwig worked extensively on vaccine development while at USAMRIID, serving on the team responsible for development of new and innovative vaccine platforms including a recombinant vaccine for Venezuelan Equine Encephalitis, and an alphavirus vaccine replicon capable of stimulating immunity to nearly any disease-causing agent. He traveled extensively in support of humanitarian and capacity-building efforts for the military including as a team leader for disease outbreak investigations in the former Zaire (Ebola virus), Colombia (Venezuelan equine encephalitis virus), and the Southwest United States (Sin Nombre virus). Dr. Ludwig received his Ph.D. from the University of Wisconsin in 1990 and is author of nearly 70 manuscripts, technical reports, book chapters, and other publications written during 30 years of relevant experience. He owns five patents resulting from his work on vaccine delivery systems and has received numerous awards and honors including the Order of Military Medical Merit, Superior Civilian Service Medal and two Achievement Medals for Civilian Service.

Last Modified Date: 20-Dec-2016